Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases

Project Information

PRECISESADS

Grant agreement ID: 115565

Project closed

Start date 1 February 2014

End date 31 January 2019

Funded under

• Specific Programme "Cooperation": Joint Technology Initiatives

Total cost € 23 098 292,00

EU contribution € 9 999 323,00

Coordinated by

UCB BIOPHARMA
Belgium

• Fast, effective treatment for autoimmune rheumatic diseases
  EN